Patent ID: 11858986
Assignee: PFIZER INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The first and second isolated nucleic acid molecules of claim 11, wherein the heavy chain or antigen-binding fragment comprises:
(a) a CDR-H1 comprising the amino acid sequence of SEQ ID NO: 37;
(b) a CDR-H2 comprising the amino acid sequence of SEQ ID NO: 38;
(c) a CDR-H3 comprising the amino acid sequence of SEQ ID NO: 39; and, wherein the light chain or antigen-binding fragment comprises:
(d) a CDR-L1 comprising the amino acid sequence of SEQ ID NO: 34;
(e) a CDR-L2 comprising the amino acid sequence of SEQ ID NO: 35; and
(f) a CDR-L3 comprising the amino acid sequence of SEQ ID NO: 36.